Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2

Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2

Mucosal immunity plays a significant role in host defense against viruses in the respiratory tract. Because the upper respiratory airway is a primary site of SARS-CoV-2 entry, immunization at the mucosa via the intranasal route could potentially lead to induction of local sterilizing immunity that p...

Full description

Bibliographic Details
Main Authors: Tuksin Jearanaiwitayakul, Mathurin Seesen, Runglawan Chawengkirttikul, Jitra Limthongkul, Suttikarn Apichirapokey, Sompong Sapsutthipas, Supaporn Phumiamorn, Panya Sunintaboon, Sukathida Ubol
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Vaccines
Subjects:
intranasal vaccine
RBD
COVID-19
nano-delivery vaccine
Online Access:https://www.mdpi.com/2076-393X/9/7/768

Internet

https://www.mdpi.com/2076-393X/9/7/768

Similar Items